Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00951691 · ClinicalTrials.gov registry record · Phase 2
Enhanced Medical Rehabilitation for Disablement
A Phase 2 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 2
- Development phase
- 25
- Enrollment target
NCT00951691: Completed Phase 2 study, sponsored by Washington University School of Medicine.
NCT00951691 is a Phase 2 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 25 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00951691, a Phase 2 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 25 participants
- Enrollment target
Study Summary
This study will develop and test a new program of enhanced medical rehabilitation for elderly people who have had an acute disabling medical event and are admitted to a skilled nursing facility for post-acute rehabilitation.
Primary Outcome
Barthel Index. Secondary Measures are gait speed and 6 minute walk.
Interventions
- BEHAVIORAL Treatment as usual
- BEHAVIORAL Enhanced acute medical rehabilitation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2009-08 |
| Est. Completion | 2012-01 |
| Phase | Phase 2 |
What the finished NCT00951691 record still lists
NCT00951691 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 2 interventions - of which Treatment as usual is the first listed.
NCT00951691 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00951691 about?
NCT00951691 is a clinical study titled "Enhanced Medical Rehabilitation for Disablement". This study will develop and test a new program of enhanced medical rehabilitation for elderly people who have had an acute disabling medical event and are admitted to a skilled nursing facility for post-acute rehabilitation.
What is the current status of trial NCT00951691?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 25 participants. The study started on 2009-08. Estimated completion is 2012-01.
What interventions are being tested in trial NCT00951691?
The interventions under investigation include: Treatment as usual (BEHAVIORAL), Enhanced acute medical rehabilitation (BEHAVIORAL).
Who is sponsoring clinical trial NCT00951691?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00951691's enrollment target sits among peer trials
25 1719th of 2000 higher than 245 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia